Trevi Therapeutics, Inc. (NASDAQ:TRVI) Q4 2025 Earnings Call Transcript March 17, 2026
Trevi Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.06, expectations were $-0.09657.
Operator: Good afternoon, and welcome to the Trevi Therapeutics Fourth Quarter and Year-End 2025 Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. Various remarks that management makes during this conference call about the company’s future...
